Description
Trasturel 150mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient, Trastuzumab, is a monoclonal antibody that specifically targets the HER2 protein, which is overexpressed in some breast and stomach cancers. By binding to HER2-positive cancer cells, Trastuzumab inhibits their growth and proliferation. It can also flag these cancer cells for destruction by the body’s immune system. Trasturel is indicated for HER2-positive breast cancer (both early-stage and metastatic) and HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. The dosage and administration are determined by a qualified healthcare professional based on the specific condition and patient’s response. Common side effects may include infusion-related reactions, fatigue, nausea, and diarrhea. Less common but serious side effects can involve heart problems. Trasturel 150mg Injection should be stored as per the manufacturer’s instructions, typically refrigerated and protected from light.
